Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
1.
J Neonatal Perinatal Med ; 16(3): 461-473, 2023.
Article in English | MEDLINE | ID: mdl-37742666

ABSTRACT

BACKGROUND: To investigate the use of calcineurin inhibitors (CNIs) in pregnant Japanese women and to evaluate their safety in infants. METHODS: Data were extracted from the claims database of the Japan Medical Data Center. The prevalence of CNIs was evaluated 180 days before pregnancy onset, during pregnancy, and within180-days post partum. We investigated the characteristics of the infants, including the presence of major malformations and their diagnoses, for 1 year after birth. RESULTS: A total of 91,865 pregnancies in 80,049 women were included. Fifty-three women were prescribed CNIs between 180-day before pregnancy onset and 180-day postpartum; 35 of the 53 women were prescribed the drugs during pregnancy, and 10 of their infants were born preterm. Three were diagnosed with major congenital malformations, such as patent ductus arteriosus. Six preterm infants presented with infant respiratory distress syndrome. CONCLUSIONS: No congenital anomalies were clearly attributable to the use of CNIs during pregnancy.

2.
Article in English | MEDLINE | ID: mdl-35092939

ABSTRACT

No studies have examined the association of the combination of n-3 polyunsaturated fatty acids (PUFAs) and n-6 PUFAs intake with psychological distress during pregnancy. To examine these associations, we divided Japanese pregnant women into 25 groups based on combining quintiles of n-3 PUFAs intake and quintiles of n-6 PUFAs intake. We conducted multivariable logistic regression analyses to assess the risk of psychological distress during pregnancy (Kessler Psychological Distress Scale ≥ 5 or 13). Compared to the third quintile of both n-3 PUFAs and n-6 PUFAs intake, the groups with unbalanced intake, high intake of both, and low intake of both were associated with a higher risk of both Kessler Psychological Distress Scale ≥ 5 and 13 in early and mid-pregnancy. Further research is needed to identify the precise combination of n-3 PUFAs and n-6 PUFAs intake associated with the lowest psychological distress during pregnancy.


Subject(s)
Fatty Acids, Omega-3 , Psychological Distress , Cohort Studies , Female , Humans , Pregnancy
3.
Nat Commun ; 10(1): 2780, 2019 06 25.
Article in English | MEDLINE | ID: mdl-31239441

ABSTRACT

In the developing central nervous system, cell departure from the apical surface is the initial and fundamental step to form the 3D, organized architecture. Both delamination of differentiating cells and repositioning of progenitors to generate outer radial glial cells (oRGs) contribute to mammalian neocortical expansion; however, a comprehensive understanding of their mechanisms is lacking. Here, we demonstrate that Lzts1, a molecule associated with microtubule components, promotes both cell departure events. In neuronally committed cells, Lzts1 functions in apical delamination by altering apical junctional organization. In apical RGs (aRGs), Lzts1 expression is variable, depending on Hes1 expression levels. According to its differential levels, Lzts1 induces diverse RG behaviors: planar division, oblique divisions of aRGs that generate oRGs, and their mitotic somal translocation. Loss-of-function of lzts1 impairs all these cell departure processes. Thus, Lzts1 functions as a master modulator of cellular dynamics, contributing to increasing complexity of the cerebral architecture during evolution.


Subject(s)
Cerebrum/growth & development , Cerebrum/metabolism , Ependymoglial Cells/metabolism , Neurogenesis , Neurons/metabolism , Tumor Suppressor Proteins/metabolism , Animals , Cell Movement , Cerebrum/cytology , Ependymoglial Cells/cytology , Mice , Mice, Transgenic , Neurons/cytology , Transcription Factor HES-1/genetics , Transcription Factor HES-1/metabolism , Tumor Suppressor Proteins/genetics
4.
Phys Chem Chem Phys ; 19(1): 59-63, 2016 Dec 21.
Article in English | MEDLINE | ID: mdl-27942633

ABSTRACT

The van der Waals compound Xe(N2)2 with a C15 Laves structure was successfully synthesised at pressures greater than 4.4 GPa. We found that, at 10 GPa, the structure reversibly transforms from a cubic to a tetragonal phase. Further compression results in changes of Xe-N compound, which could result in the enhancement of orbital interactions between the xenon and nitrogen atoms.

5.
Mol Psychiatry ; 20(4): 459-71, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25070536

ABSTRACT

Human mutations in PQBP1, a molecule involved in transcription and splicing, result in a reduced but architecturally normal brain. Examination of a conditional Pqbp1-knockout (cKO) mouse with microcephaly failed to reveal either abnormal centrosomes or mitotic spindles, increased neurogenesis from the neural stem progenitor cell (NSPC) pool or increased cell death in vivo. Instead, we observed an increase in the length of the cell cycle, particularly for the M phase in NSPCs. Corresponding to the developmental expression of Pqbp1, the stem cell pool in vivo was decreased at E10 and remained at a low level during neurogenesis (E15) in Pqbp1-cKO mice. The expression profiles of NSPCs derived from the cKO mouse revealed significant changes in gene groups that control the M phase, including anaphase-promoting complex genes, via aberrant transcription and RNA splicing. Exogenous Apc4, a hub protein in the network of affected genes, recovered the cell cycle, proliferation, and cell phenotypes of NSPCs caused by Pqbp1-cKO. These data reveal a mechanism of brain size control based on the simple reduction of the NSPC pool by cell cycle time elongation. Finally, we demonstrated that in utero gene therapy for Pqbp1-cKO mice by intraperitoneal injection of the PQBP1-AAV vector at E10 successfully rescued microcephaly with preserved cortical structures and improved behavioral abnormalities in Pqbp1-cKO mice, opening a new strategy for treating this intractable developmental disorder.


Subject(s)
Genetic Therapy , Microcephaly/genetics , Microcephaly/therapy , Neural Stem Cells/physiology , Nuclear Proteins/deficiency , Adenoviridae/genetics , Animals , Apc4 Subunit, Anaphase-Promoting Complex-Cyclosome/metabolism , Apoptosis/genetics , Brain/pathology , Carrier Proteins/genetics , Cell Adhesion Molecules/metabolism , Cell Cycle , Cell Proliferation , DNA-Binding Proteins , Disease Models, Animal , Embryo, Mammalian , Female , Humans , Male , Mice , Mice, Knockout , Microcephaly/pathology , Nestin/genetics , Nestin/metabolism , Neurogenesis , Nuclear Proteins/genetics , Synapsins/genetics , Synapsins/metabolism
6.
Diabetes Res Clin Pract ; 54(1): 41-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11532329

ABSTRACT

This study was designed to investigate the prevalence of neurological symptoms in diabetic patients living in Saitama Prefecture, Japan using 13-item questionnaire. A total of 6472 outpatients with diabetes (3417 men and 3055 women) were recruited from 100 centers. Mean age and mean disease duration were 60.9-year old and 10.4 years, respectively. The questionnaire for monitoring of neurological symptoms was completed at the clinic or hospital visited, and Achilles' tendon reflex, ophthalmologic, blood and urinary examinations were also performed. Of the 6472 patients, 84.8% suffered from a mean of 3.3+/-2.2 neurological symptoms. However, half of these symptoms were not considered to be those of diabetic neuropathy by attending physicians. "Feeling as if a piece of paper is attached to the sole of the foot," "stinging and prickling sensations in feet," and "pain in feet" were the most common symptoms of diabetic neuropathy. The prevalence of diabetic neuropathy as determined by attending physician increased with disease duration and worse control of diabetes. This study found that the majority of diabetics were suffered from neurological symptoms, although half of such symptoms were not considered to be those of diabetic neuropathy by physicians. Furthermore, it is important for diabetics to be diagnosed and treated earlier to prevent progression to severe neuropathic complications by means of optimal glycemic control and use of some chemicals such as aldose reductase inhibitor, and to develop this study to evaluate the efficacy of treatments.


Subject(s)
Diabetes Mellitus, Type 1/physiopathology , Diabetes Mellitus, Type 2/physiopathology , Diabetic Neuropathies/epidemiology , Diabetic Neuropathies/physiopathology , Aged , Cross-Sectional Studies , Diabetic Neuropathies/blood , Female , Glycated Hemoglobin/analysis , Humans , Japan/epidemiology , Male , Middle Aged , Neurologic Examination , Outpatients , Prevalence , Reflex , Skin/innervation , Surveys and Questionnaires
7.
Nature ; 408(6812): 593-6, 2000 Nov 30.
Article in English | MEDLINE | ID: mdl-11117747

ABSTRACT

Cellular diversity during development arises in part from asymmetric divisions, which generate two distinct cells by transmitting localized determinants from a progenitor cell into one daughter cell. In Drosophila, neuroblasts undergo typical asymmetric divisions to produce another neuroblast and a ganglion mother cell. At mitosis, neural fate determinants, including Prospero and Numb, localize to the basal cortex, from which the ganglion mother cell buds off; Inscuteable and Bazooka, which regulate spindle orientation, localize apically. Here we show that a tumour-suppressor protein, Lethal giant larvae (Lgl), is essential for asymmetric cortical localization of all basal determinants in mitotic neuroblasts, and is therefore indispensable for neural fate decisions. Lgl, which itself is uniformly cortical, interacts with several types of Myosin to localize the determinants. Another tumour-suppressor protein, Lethal discs large (Dlg), participates in this process by regulating the localization of Lgl. The localization of the apical components is unaffected in lgl or dlg mutants. Thus, Lgl and Dlg act in a common process that differentially mediates cortical protein targeting in mitotic neuroblasts, and that creates intrinsic differences between daughter cells.


Subject(s)
Diacetyl/analogs & derivatives , Drosophila Proteins , Insect Proteins/physiology , Neurons/cytology , Tumor Suppressor Proteins , Amino Acid Sequence , Animals , Cell Cycle Proteins/genetics , Cell Cycle Proteins/physiology , Cell Differentiation/physiology , Cell Division/physiology , Cell Lineage , Diacetyl/pharmacology , Drosophila/embryology , Drosophila/genetics , Genes, Tumor Suppressor , Insect Proteins/genetics , Juvenile Hormones/physiology , Membrane Proteins/genetics , Membrane Proteins/physiology , Mitosis , Molecular Sequence Data , Mutation , Myosin Heavy Chains/genetics , Myosin Heavy Chains/physiology , Myosins/physiology
8.
J Exp Clin Cancer Res ; 19(2): 219-23, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10965822

ABSTRACT

We previously demonstrated that cyclooxygenase-2 (COX-2) was predominantly expressed in macrophages of sporadic human colonic adenomas; however, the role of COX-2-expressing cells during colon carcinogenesis has not yet been elucidated. In the present study, we showed the effect of PGE, on vascular endothelial growth factor (VEGF) production by PMA-differentiated U937 cells, a human macrophage model (H-Mac), and by human colon cancer cells T84. PGE1 dramatically induced VEGF production by H-Mac, but not that by T84. PGE1 significantly increased intracellular cAMP formation by H-Mac, but only modestly increased that by T84. 8-bromo-cAMP and cholera toxin also increased VEGF production by H-Mac. In contrast, neither of these agents modulated VEGF production by T84. EP2 and EP4 (PGE specific receptors) mRNA was expressed in both cells. PG dramatically increased VEGF production by activated macrophages, but not by cancer cells, through a specific PGE receptor-mediated process. These findings suggest that PGs produced by COX-2-expressing macrophages induce VEGF production by macrophages, but not by cancer cells, in an autocrine fashion.


Subject(s)
Colonic Neoplasms/drug therapy , Dinoprostone/pharmacology , Endothelial Growth Factors/biosynthesis , Lymphokines/biosynthesis , Macrophages/drug effects , Adjuvants, Immunologic/pharmacology , Cholera Toxin/pharmacology , Colonic Neoplasms/metabolism , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Cyclooxygenase 2 , DNA Primers/chemistry , Humans , Isoenzymes/metabolism , Macrophages/metabolism , Membrane Proteins , Prostaglandin-Endoperoxide Synthases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Prostaglandin E/genetics , Receptors, Prostaglandin E/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Up-Regulation , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
9.
Curr Opin Neurobiol ; 10(1): 38-44, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10679433

ABSTRACT

Recent studies of Drosophila neural precursor cells have unveiled the essential roles played by asymmetric cell divisions in the determination of cell fates during neural development. Our understanding now extends to the molecular nature of the cell polarity that underlies asymmetric divisions. This polarity is conserved among neural stem cells, epithelial cells and fertilized eggs.


Subject(s)
Cell Polarity , Drosophila melanogaster/cytology , Drosophila melanogaster/embryology , Neurons/cytology , Stem Cells/cytology , Animals , Cell Differentiation , Cell Division , Central Nervous System/cytology , Central Nervous System/embryology , Conserved Sequence , Epithelial Cells/cytology , Epithelial Cells/metabolism , Neurons/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Spindle Apparatus/metabolism , Stem Cells/metabolism
10.
Int J Cancer ; 83(4): 470-5, 1999 Nov 12.
Article in English | MEDLINE | ID: mdl-10508481

ABSTRACT

Cyclooxygenase (COX)-2 is a possible molecular target for suppression of colon carcinogenesis by non-steroidal anti-inflammatory drugs (NSAIDs). However, the expression of COX-2 in human colonic tumors during the adenoma-carcinoma sequence has not been elucidated. In the present study, we examined immuno-histochemically the expression and localization of the COX-2 protein in human colonic adenomas and cancers. Twelve human colonic adenomas and 9 advanced cancers were studied. Immunoreactive COX-2 was predominantly and strongly expressed in sub-epithelial interstitial cells broadly present in the surface area of adenomas. The staining pattern of macrophages was similar to that observed for COX-2 in adenomas. Adjacent normal colonic mucosa was negative for COX-2 expression. In contrast, COX-2 was relatively weakly expressed in both tumor cells and interstitial cells in advanced colon cancers. In conclusion, the target of NSAIDs in preventing colon carcinogenesis may be the COX-2 expressed in interstitial cells, possibly macrophages, of colonic adenomas.


Subject(s)
Adenoma/enzymology , Carcinoma/enzymology , Colonic Neoplasms/enzymology , Isoenzymes/biosynthesis , Macrophages/enzymology , Prostaglandin-Endoperoxide Synthases/biosynthesis , Adenoma/metabolism , Adult , Aged , Aged, 80 and over , Antibody Specificity , Antigens, CD/biosynthesis , Antigens, Differentiation, Myelomonocytic/biosynthesis , Blotting, Western , Carcinoma/metabolism , Colonic Neoplasms/metabolism , Cyclooxygenase 2 , Humans , Immunohistochemistry , Isoenzymes/immunology , Macrophages/metabolism , Membrane Proteins , Middle Aged , Prostaglandin-Endoperoxide Synthases/immunology
11.
Eur J Pharmacol ; 367(1): 131-8, 1999 Feb 12.
Article in English | MEDLINE | ID: mdl-10082276

ABSTRACT

Nonsteroidal anti-inflammatory drugs which inhibit cyclooxygenase have been reported to suppress colon carcinogenesis. However the mechanism has not yet been elucidated. Growth factors such as hepatocyte growth factor, which are produced by fibroblasts, have been shown to be important in carcinogenesis and the progression of various human cancers. In the present study, we tested the hypothesis that nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor expression through an endogenous prostaglandin-mediated pathway in cultured human colonic fibroblasts. Human colonic fibroblasts were obtained from a resected colon and cultured. Hepatocyte growth factor and prostaglandin E2 were measured by enzyme-linked immunosorbent assay. Induction of cyclooxygenase-1 and cyclooxygenase-2 protein was estimated by immunoblotting. Prostaglandins increased hepatocyte growth factor production significantly in a dose- and time-dependent manner. Cholera toxin and 8-bromo cAMP also stimulated hepatocyte growth factor production. Further, prostaglandin E1 significantly increased cellular cAMP. The prostaglandin EP2 and EP4 receptors were detected by reverse transcription-polymerase chain reaction. Interleukin-1beta dramatically increased prostaglandin E2 production and significantly stimulated hepatocyte growth factor synthesis. Interleukin-1beta induced cyclooxygenase-2 but not cyclooxygenase-1 protein. Indomethacin significantly reduced interleukin-1beta-induced prostaglandin E2 release and hepatocyte growth factor production. These results suggest that prostaglandin is a factor for the production of hepatocyte growth factor by human colonic fibroblasts. Nonsteroidal anti-inflammatory drugs may suppress colon carcinogenesis, in part, through the suppression of hepatocyte growth factor expression by inhibiting endogenous prostaglandin production.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Colonic Neoplasms/prevention & control , Hepatocyte Growth Factor/biosynthesis , Alprostadil/pharmacology , Cell Survival/drug effects , Cells, Cultured , Cholera Toxin/pharmacology , Colon/cytology , Colon/drug effects , Colon/metabolism , Colonic Neoplasms/metabolism , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Cyclooxygenase 1 , Cyclooxygenase 2 , Dinoprostone/biosynthesis , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Expression/drug effects , Humans , Indomethacin/pharmacology , Interleukin-1/pharmacology , Isoenzymes/biosynthesis , Isoenzymes/drug effects , Membrane Proteins , Mucous Membrane/cytology , Mucous Membrane/drug effects , Mucous Membrane/metabolism , Prostaglandin-Endoperoxide Synthases/biosynthesis , Prostaglandin-Endoperoxide Synthases/drug effects , Prostaglandins/pharmacology , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Receptors, Prostaglandin E/genetics , Receptors, Prostaglandin E, EP2 Subtype , Receptors, Prostaglandin E, EP4 Subtype
12.
Development ; 126(3): 443-56, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9876174

ABSTRACT

Like other tissues and organs in vertebrates, multipotential stem cells serve as the origin of diverse cell types during genesis of the mammalian central nervous system (CNS). During early development, stem cells self-renew and increase their total cell numbers without overt differentiation. At later stages, the cells withdraw from this self-renewal mode, and are fated to differentiate into neurons and glia in a spatially and temporally regulated manner. However, the molecular mechanisms underlying this important step in cell differentiation remain poorly understood. In this study, we present evidence that the expression and function of the neural-specific transcription factors Mash-1 and Prox-1 are involved in this process. In vivo, Mash-1- and Prox-1-expressing cells were defined as a transient proliferating population that was molecularly distinct from self-renewing stem cells. By taking advantage of in vitro culture systems, we showed that induction of Mash-1 and Prox-1 coincided with an initial step of differentiation of stem cells. Furthermore, forced expression of Mash-1 led to the down-regulation of nestin, a marker for undifferentiated neuroepithelial cells, and up-regulation of Prox-1, suggesting that Mash-1 positively regulates cell differentiation. In support of these observations in vitro, we found specific defects in cellular differentiation and loss of expression of Prox-1 in the developing brain of Mash-1 mutant mice in vivo. Thus, we propose that induction of Mash-1 and Prox-1 is one of the critical molecular events that control early development of the CNS.


Subject(s)
Central Nervous System/growth & development , DNA-Binding Proteins/physiology , Helix-Loop-Helix Motifs , Homeodomain Proteins/physiology , Stem Cells/cytology , Transcription Factors/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors , Blotting, Western , Cell Differentiation , Cells, Cultured , Central Nervous System/cytology , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/genetics , In Situ Hybridization , Mice , Mice, Knockout , Rabbits , Rats , Transcription Factors/biosynthesis , Transcription Factors/genetics , Tumor Suppressor Proteins
13.
Genes Dev ; 12(17): 2724-34, 1998 Sep 01.
Article in English | MEDLINE | ID: mdl-9732270

ABSTRACT

Morphogen gradients of secreted molecules play critical roles in the establishment of the spatial pattern of gene expression. During midgut development in Drosophila, secreted molecules of Decapentaplegic (Dpp) and Wingless (Wg) establish unique transcriptional regulation within target cells to specify the resultant cell types. Here we report the identification of a novel homeobox gene, defective proventriculus (dve), which is required for the midgut specification under the control of Dpp and Wg. In dve mutants, two distinct parts of the midgut, the proventriculus and middle midgut, are abnormally organized. The Wg signal regulates dve expression during proventriculus development. On the other hand, dve is a downstream target of Dpp in the middle midgut and defines the functional specificity of copper cells along with another Dpp target gene, labial. Thus, the dve gene acts under the two distinct extracellular signals at distant parts of the midgut primordia.


Subject(s)
Drosophila Proteins , Drosophila/embryology , Drosophila/genetics , Gene Expression Regulation, Developmental , Genes, Homeobox , Genes, Insect , Homeodomain Proteins/genetics , Insect Proteins/genetics , Proto-Oncogene Proteins/genetics , Amino Acid Sequence , Animals , Body Patterning/genetics , Chromosome Mapping , Digestive System/embryology , Embryo, Nonmammalian/physiology , Enhancer Elements, Genetic , Genes, Lethal , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/chemistry , Insect Proteins/biosynthesis , Molecular Sequence Data , Proto-Oncogene Proteins/biosynthesis , Sequence Alignment , Sequence Homology, Amino Acid , Wnt1 Protein
14.
Development ; 125(20): 4089-98, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9735369

ABSTRACT

When neuroblasts divide, prospero protein and mRNA segregate asymmetrically into the daughter neuroblast and sibling ganglion mother cell. miranda is known to localize prospero protein to the basal cell cortex of neuroblasts while the staufen RNA-binding protein mediates prospero mRNA localization. Here we show that miranda is required for asymmetric staufen localization in neuroblasts. Analyses using miranda mutants reveal that prospero and staufen interact with miranda under the same cell-cycle-dependent control. miranda thus acts to partition both prospero protein and mRNA. Furthermore, miranda localizes prospero and staufen to the basolateral cortex in dividing epithelial cells, which express the three proteins prior to neurogenesis. Our observations suggest that the epithelial cell and neuroblast (both of epithelial origin) share the same molecular machinery for creating cellular asymmetry.


Subject(s)
Cell Cycle Proteins/physiology , Drosophila Proteins , Drosophila melanogaster/embryology , Mitosis , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Nuclear Proteins/metabolism , RNA-Binding Proteins/metabolism , Transcription Factors , Alleles , Animals , Cell Cycle Proteins/genetics , Cell Polarity/genetics , Drosophila melanogaster/cytology , Drosophila melanogaster/genetics , Ectoderm/cytology , Epithelial Cells/cytology , Epithelial Cells/metabolism , Ganglia, Invertebrate/cytology , Genes, Insect , Immunohistochemistry , In Situ Hybridization , Mitosis/genetics , Nerve Tissue Proteins/genetics , Neurons/cytology , Nuclear Proteins/genetics , Sequence Deletion , Stem Cells
15.
Biochem Biophys Res Commun ; 245(2): 567-71, 1998 Apr 17.
Article in English | MEDLINE | ID: mdl-9571196

ABSTRACT

Prostaglandins (PGs), hepatocyte growth factor (HGF), and induction of cyclooxygenase (PG synthetase, COX) play important roles in the repair process of gastric mucosa. We hypothesized that nonsteroidal anti-inflammatory drugs (NSAIDs), including indomethacin (IND), retard the healing of ulcers by suppressing these factors. In this study, we investigated the effects of cytokines, growth factors, and IND on production of PG and HGF, and induction of COX using cultured human gastric fibroblasts. Exogenous PGs significantly increased HGF production in a dose-dependent manner. Among various potential stimulants tested, interleukin-1 beta (IL-1 beta) dramatically increased PGE2 production and significantly stimulated HGF production. IL-1 beta induced COX-2 but not COX-1 protein. IND significantly reduced both basal and IL-1 beta-induced PGE2 release and HGF production. These results suggest that the IL-1 beta-PG-HGF pathway plays a role in the repair process of gastric mucosa. Further, NSAIDs may delay the healing of gastric mucosal ulcer, in part through suppression of HGF expression via inhibition of endogenous PG production.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Gastric Mucosa/drug effects , Hepatocyte Growth Factor/pharmacology , Prostaglandins/pharmacology , Alprostadil/pharmacology , Cholera Toxin/pharmacology , Cyclic AMP/analogs & derivatives , Cyclic AMP/metabolism , Cyclooxygenase 1 , Cyclooxygenase 2 , Dinoprostone/pharmacology , Fibroblasts , Gene Expression Regulation, Enzymologic/genetics , Humans , Indomethacin/pharmacology , Interleukin-1/pharmacology , Isoenzymes/metabolism , Membrane Proteins , Peptic Ulcer , Prostaglandin Antagonists/pharmacology , Prostaglandin-Endoperoxide Synthases/metabolism , Stomach Ulcer/metabolism , Transforming Growth Factor alpha/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
16.
Biochem Biophys Res Commun ; 245(1): 70-4, 1998 Apr 07.
Article in English | MEDLINE | ID: mdl-9535785

ABSTRACT

The regulation of cyclin D-dependent kinase activity in tissue regeneration in vivo has not been fully described. In young adult rat liver after 70% partial hepatectomy, the association of cyclin D1 with cdk4 was significantly promoted during G1 phase and was maximal at 18 hr, corresponding mainly to late G1. Cyclin D1-dependent kinase activity also strongly increased during G1 phase. The timing of the induction of cyclin D1 / cdk4 complex assembly correlated well with that of cyclin D1-dependent kinase activity. At 18 hr after partial hepatectomy, the amounts of CDK inhibitors p21(CIP1) and p27(KIP1) were also maximal, while only one-tenth of p21(CIP1) and of p27(KIP1) was associated with cyclin D1. These findings suggest that cyclin D1, cdk4 and their association act as promoting factors, and that both p21(CIP1) and p27(KIP1) may have physiological functions as adaptor proteins in additions to their roles as CDK inhibitors in rat liver regeneration.


Subject(s)
Cell Cycle Proteins , Cyclin-Dependent Kinases/metabolism , Liver Regeneration/physiology , Proto-Oncogene Proteins , Tumor Suppressor Proteins , Animals , Cell Cycle/physiology , Cyclin D1/metabolism , Cyclin-Dependent Kinase 4 , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclin-Dependent Kinases/antagonists & inhibitors , Cyclins/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Developmental/genetics , Hepatectomy , Immunochemistry , Interphase/physiology , Male , Microtubule-Associated Proteins/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Inbred F344
17.
Endoscopy ; 30(9): 774-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9932757

ABSTRACT

BACKGROUND: Endoscopic ligation can be used for bleeding lesions in non-fibrotic tissue; however, only small numbers of patients with non-esophageal variceal upper gastrointestinal hemorrhage have been treated in this way. To evaluate the utility of the technique, we performed the procedure to treat hemorrhage not from esophageal varices during emergency endoscopy. PATIENTS AND METHODS: Bleeding was identified from gastric Dieulafoy's ulcers (n=4), duodenal ulcers (n=3), gastric angiodysplasia (n=2) and Mallory-Weiss tears (n=3). The bleeding points were aspirated and controlled by endoscopic ligation and complete hemostasis was achieved in all cases. RESULTS: Although these lesions were located in difficult areas where endoscopic injection therapy and clipping sometimes fail, endoscopic ligation was performed easily and effectively without complications. Six of the patients had severe underlying disease, including acute and chronic myelogenous leukemia, liver cirrhosis and chronic renal failure; none suffered deterioration in their general condition after endoscopic ligation. CONCLUSIONS: Our findings suggest that endoscopic ligation is an easy and effective method of treatment for patients with gastrointestinal hemorrhage not from esophageal varices, and is safe even in patients with poor general health.


Subject(s)
Duodenal Ulcer/surgery , Gastric Antral Vascular Ectasia/surgery , Gastrointestinal Hemorrhage/surgery , Hemostasis, Endoscopic , Mallory-Weiss Syndrome/surgery , Stomach Ulcer/surgery , Adult , Aged , Aged, 80 and over , Duodenal Ulcer/complications , Duodenal Ulcer/diagnosis , Endoscopy, Digestive System , Esophageal and Gastric Varices/diagnosis , Female , Follow-Up Studies , Gastric Antral Vascular Ectasia/complications , Gastric Antral Vascular Ectasia/diagnosis , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Hemostasis, Endoscopic/methods , Humans , Ligation , Male , Mallory-Weiss Syndrome/complications , Mallory-Weiss Syndrome/diagnosis , Middle Aged , Peptic Ulcer Hemorrhage/diagnosis , Peptic Ulcer Hemorrhage/surgery , Retrospective Studies , Stomach Ulcer/complications , Stomach Ulcer/diagnosis
18.
Nature ; 390(6660): 625-9, 1997 Dec 11.
Article in English | MEDLINE | ID: mdl-9403694

ABSTRACT

Asymmetric cell division is a general process used in many developmental contexts to create two differently fated cells from a single progenitor cell. Intrinsic mechanisms like the asymmetric transmission of cell-fate determinants during cell division, and extrinsic cell-interaction mechanisms, can mediate asymmetric divisions. During embryonic development of the Drosophila central nervous system, neural stem cells called neuroblasts divide asymmetrically to produce another multipotent neuroblast and a ganglion mother cell (GMC) of more restricted developmental potential. Intrinsic mechanisms promote asymmetric division of neuroblasts: for example, the transcription factor Prospero localizes to the basal cell cortex of mitotic neuroblasts and then segregates exclusively into the GMC, which buds off from the basal side of the neuroblast. In the GMC, Prospero translocates to the nucleus, where it establishes differential gene expression between sibling cells. Here we report the identification of a gene, miranda, which encodes a new protein that co-localizes with Prospero in mitotic neuroblasts, tethers Prospero to the basal cortex of mitotic neuroblasts, directing Prospero into the GMC, and releases Prospero from the cell cortex within GMCs. miranda thus creates intrinsic differences between sibling cells by mediating the asymmetric segregation of a transcription factor into only one daughter cell during neural stem-cell division.


Subject(s)
Cell Cycle Proteins/physiology , Cell Differentiation/physiology , Cell Division/physiology , Drosophila Proteins , Nerve Tissue Proteins/physiology , Neurons/cytology , Nuclear Proteins/physiology , Transcription Factors/physiology , Alleles , Amino Acid Sequence , Animals , Binding Sites , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Differentiation/genetics , Cloning, Molecular , Drosophila/cytology , Drosophila/embryology , Drosophila/genetics , Female , Ganglia, Invertebrate/cytology , Genes, Insect , Male , Molecular Sequence Data , Mutagenesis , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Protein Binding , Stem Cells/cytology , Stem Cells/metabolism , Transcription Factors/metabolism
20.
Am J Gastroenterol ; 92(4): 659-62, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9128318

ABSTRACT

OBJECTIVES: Fast and simple in vitro methods of accurately assaying anti-Helicobacter pylori (H. pylori) activity are needed to facilitate the selection of optimal drugs for the eradication of H. pylori. With that purpose in mind, we developed a broth microdilution technique that uses a 96-well flat-bottom microplate. METHODS: Clinical isolates of H. pylori were placed in 25-cm2 tissue culture flasks and were grown in an atmosphere of 5% CO2 in air at 37 degrees C and 100% humidity. Then they were inoculated in 96-well flat-bottom microplates. After 24 h, the bacterial growth was assessed by automatic measurement at A450 with a microplate reader. Minimum inhibitory concentrations (MICs) of 11 drugs against H. pylori and the effect of two-drug combinations were respectively evaluated by the broth microdilution technique and by calculating the fractional inhibitory concentration index according to the checkerboard titration method. RESULTS: The MICs of all drugs tested with this system roughly agreed with those of previous reports in which the agar dilution method was used. The MIC of lansoprazole, a proton pump inhibitor, was low (0.88 microg/ml) and surpassed that of metronidazole (3.15 microg/ml). The effect of the combination of macrolide antibiotics with tetracycline was favorable. The proton pump inhibitor demonstrated a strong additive effect with macrolide antibiotics and fostered the activity of ecabet sodium (mucosal protective agent). CONCLUSION: This system could estimate the MIC of individual drugs quickly and simply, and could accurately measure the efficacy of two-drug combinations in vitro.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Ulcer Agents/pharmacology , Helicobacter pylori/drug effects , Bacteriological Techniques , Culture Media , Dose-Response Relationship, Drug , Drug Therapy, Combination , Gastric Mucosa/microbiology , Helicobacter pylori/growth & development , Helicobacter pylori/isolation & purification , Humans , Microbial Sensitivity Tests/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...